✦ LIBER ✦

Aggressive Lipid Lowering in Postcoronary Angioplasty Patients With Elevated Cholesterol (the Lovastatin Restenosis Trial)

✍ Scribed by Stephen J Boccuzzi PhD; William S Weintraub MD; Andrzej S Kosinski PhD; James B Roehm MS; J Larry Klein

Book ID: 113979075
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 143 KB
Volume: 81
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(97)00980-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Can Aggressive Lipid Lowering Using Low-

Can Aggressive Lipid Lowering Using Low-Density Lipoprotein Apheresis Prevent Restenosis After Percutaneous Transluminal Coronary Angioplasty in Patients with Normocholesterolemia?

✍ Kazuhito Yamashita; Hiromi Tasaki; Yuki Tsuda; Etsuro Himeno; Yasuhide Nakashima 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 715 KB

Congestive heart failure is associated w

Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease: Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)

✍ Ingar Holme; Timo E. Strandberg; Ole Faergeman; John J.P. Kastelein; Anders G. O 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Prevention of coronary and stroke events

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

✍ P.S. Sever; B. Dahlof; N.R. Poulter 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Prevention of coronary and stroke events

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

✍ Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Ca 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 197 KB

Prevention of Coronary and Stroke Events

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial

✍ Sever, Peter S; Dahl??f, Bj??rn; Poulter, Neil R; Wedel, Hans; Beevers, Gareth; 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 876 KB

Plasma Triglycerides and Cardiovascular

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

✍ Ole Faergeman; Ingar Holme; Rana Fayyad; Sonal Bhatia; Scott M. Grundy; John J.P 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 471 KB